Non-homologous use of adipose-derived cell and tissue therapies: Osteoarthritis as a case study.

Frazier, Trivia; March, Keith; Garza, Jaime R; Bunnell, Bruce A; Darr, Kevin F; Rogers, Emma; Hamel, Katie; Gimble, Jeffrey M.

Frazier T; Obatala Sciences, New Orleans, LA, United States of America.
March K; Tulane University, New Orleans, LA, United States of America.
Garza JR; University of Florida, Gainesville, FL, United States of America.
Bunnell BA; Tulane University, New Orleans, LA, United States of America.
Darr KF; University of Texas Health Sciences Center - San Antonio, San Antonio, TX, United States of America.
Rogers E; University of North Texas Health Science Center, Ft. Worth, TX, United States of America.
Hamel K; Covington Orthopedics Sports Medicine Institute, Covington, LA, United States of America.
Gimble JM; Obatala Sciences, New Orleans, LA, United States of America.

Bone Rep ; 17: 101601, 2022 Dec.

Article en En | MEDLINE | ID: mdl-35874168

Palabras clave

ASC, Adipose Stromal/Stem Cells; Adipose; CBER, Center for Biologics Evaluation and Research; HCT/P, Human Cells, Tissues, and Cell/Tissue related Products; MFAT, MicroFragmented Adipose Tissue; Microfragmented fat; OA, Osteoarthritis; Osteoarthritis; Regenerative medicine; Regulatory agency; SVF, Stromal Vascular Fraction Cells; Stromal/stem cells